Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TSE:CRDL
Stock Latest News
Company Announcements
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
11d ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
13d ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
18d ago
6K
CRDL
Premium
The Fly
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
27d ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
27d ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
1M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
1M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
2M ago
6K
CRDL
Premium
Pre-Earnings
CRDL Upcoming Earnings Report: What to Expect?
2M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
3M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
3M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
4M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
4M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
4M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
4M ago
CRDL
Premium
The Fly
Cardiol Therapeutics trading resumes
4M ago
CRDL
Premium
The Fly
Cardiol Therapeutics trading halted, news pending
4M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis
4M ago
6K
CRDL
Premium
Ratings
Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
6M ago
CRDL
Premium
TipRanks Newswire
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
6M ago
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
6M ago
6K
CRDL
Premium
Company Announcements
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress
6M ago
CRDL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
